Menu
GeneBe

GPT

glutamic--pyruvic transaminase

Basic information

Region (hg38): 8:144502972-144507174

Links

ENSG00000167701NCBI:2875OMIM:138200HGNC:4552Uniprot:P24298AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GPT gene.

  • Inborn genetic diseases (25 variants)
  • not provided (23 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
2
clinvar
10
missense
25
clinvar
5
clinvar
4
clinvar
34
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
2
clinvar
3
Total 0 0 26 15 6

Variants in GPT

This is a list of pathogenic ClinVar variants found in the GPT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-144504326-C-T not specified Uncertain significance (Feb 10, 2022)2396520
8-144504336-C-A Likely benign (Dec 31, 2019)710733
8-144504339-T-A not specified Uncertain significance (Oct 27, 2023)3102082
8-144504344-C-G GLUTAMIC PYRUVATE TRANSAMINASE POLYMORPHISM Benign (Mar 01, 1997)16088
8-144504390-G-A not specified Uncertain significance (Dec 17, 2021)3102087
8-144504396-G-A not specified Uncertain significance (Feb 27, 2023)2458077
8-144504414-T-C not specified Uncertain significance (Oct 27, 2021)2257678
8-144504417-G-A not specified Uncertain significance (Jul 12, 2022)2399145
8-144504462-G-A not specified Uncertain significance (Apr 27, 2022)2262298
8-144504615-G-A Likely benign (Jun 08, 2018)714261
8-144504634-C-T not specified Uncertain significance (Dec 13, 2022)2358946
8-144504646-G-A not specified Uncertain significance (Jan 23, 2024)3102081
8-144504672-G-A Benign (Oct 24, 2018)710602
8-144504703-C-T Likely benign (Dec 31, 2019)737701
8-144504778-C-T not specified Uncertain significance (Nov 30, 2021)2269504
8-144504824-C-T Likely benign (Feb 08, 2018)723955
8-144504838-G-A Benign (Dec 31, 2019)773406
8-144504845-G-A Likely benign (Dec 31, 2019)720312
8-144504847-G-A not specified Uncertain significance (Jun 05, 2023)2570046
8-144505017-C-T Likely benign (May 11, 2018)743546
8-144505077-C-T Likely benign (Mar 09, 2018)747412
8-144505129-G-A not specified Uncertain significance (Aug 12, 2021)2405091
8-144505286-G-A not specified Uncertain significance (Oct 20, 2023)3102083
8-144505289-C-T not specified Uncertain significance (Jan 31, 2022)2223807
8-144505317-C-T Likely benign (Aug 08, 2018)740651

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GPTprotein_codingprotein_codingENST00000394955 114202
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.59e-190.00067612558301441257270.000573
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.003873351.150.00002613161
Missense in Polyphen170136.411.24621329
Synonymous-3.622051491.380.00001241031
Loss of Function-0.7572622.21.170.00000106240

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005190.000508
Ashkenazi Jewish0.0001080.0000992
East Asian0.001260.00125
Finnish0.00009890.0000924
European (Non-Finnish)0.0007960.000730
Middle Eastern0.001260.00125
South Asian0.0006540.000653
Other0.0003520.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. Participates in cellular nitrogen metabolism and also in liver gluconeogenesis starting with precursors transported from skeletal muscles (By similarity). {ECO:0000250}.;
Pathway
Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Pyruvate Carboxylase Deficiency;Primary Hyperoxaluria Type I;Argininemia;2-Hydroxyglutric Aciduria (D And L Form);Lactic Acidemia;Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Glucose-Alanine Cycle;Alanine Metabolism;Urea Cycle;Homocarnosinosis;Hyperinsulinism-Hyperammonemia Syndrome;Succinic semialdehyde dehydrogenase deficiency;Ornithine Transcarbamylase Deficiency (OTC Deficiency);4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;Glutamate Metabolism;Alanine and aspartate metabolism;Cori Cycle;Alanine Aspartate Asparagine metabolism;Glutamate Glutamine metabolism;Metabolism of amino acids and derivatives;Glycolysis Gluconeogenesis;Metabolism;alanine biosynthesis/degradation;Amino acid synthesis and interconversion (transamination) (Consensus)

Recessive Scores

pRec
0.815

Intolerance Scores

loftool
0.430
rvis_EVS
0.29
rvis_percentile_EVS
71.6

Haploinsufficiency Scores

pHI
0.137
hipred
N
hipred_score
0.284
ghis
0.427

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.230

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gpt
Phenotype
skeleton phenotype;

Gene ontology

Biological process
cellular amino acid biosynthetic process;L-alanine catabolic process
Cellular component
cytosol;extracellular exosome
Molecular function
L-alanine:2-oxoglutarate aminotransferase activity;pyridoxal phosphate binding